gut.bmj1d
P33 Sera metabolite changes in obesity-induced MASLD, assayed with metabolomic approaches
Background Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), formerly known as Non-alcoholic fatty liver disease (NAFLD) is one of the leading causes of chronic liver disease, ...
gut.bmj1d
Laserlithotripsy of common bile duct stones.
Endoscopic retrograde laser lithotripsy of common bile duct stones is a new technique which can be carried out through the endoscope without anaesthesia using ordinary endoscopic equipment. In the ...
gut.bmj2d
P10 Splenic iron assessment in haemochromatosis
1 Cambridge Liver Unit, Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK 2 Department of Radiology, University of Cambridge and Cambridge University ...
gut.bmj2d
O13 The benefits of a community liaison officer for patients with liver disease
Background Health inequalities, liver disease (LD) and cancer rates are higher than average within our locality, due to the link between deprivation and LD prevalence. The NHS England funded Community ...
gut.bmj2d
P77 A critical review of the patient experience of virtual hepatology clinics in the post-pandemic era
Hepatology virtual clinics (VC) have existed in selected areas for some years. The SARS-CoV-2 pandemic resulted in mass up-scaling and automated use of VC across the UK. Subsequently, some clinics ...
gut.bmj3d
Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture
a Pancreatic Research Group, Department of Gastroenterology, Prince of Wales Hospital and University of New South Wales, Sydney, Australia, b Mount Sinai School of Medicine, New York, USA Associate ...
gut.bmj3d
Depression in individuals who subsequently develop inflammatory bowel disease: a population-based nested case–control study
Correspondence to Dr Richard C Pollok, Gastroenterology, St George's University Hospitals NHS Foundation Trust, London SW17 0QT, UK; richard.pollok{at}nhs.net Objective Depression is a potential risk ...
gut.bmj3d
Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease
Third Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan Dr M Noguchi, Third Department of Internal Medicine, Tohoku University School of Medicine, 1–1 Seiryo-Machi, ...
gut.bmj4d
Gallstones after ileostomy and ileal resection.
One hundred and eight patients with ileostomies were investigated for cholelithiasis at routine annual review in a large Ileostomy Clinic. Gallstones were demonstrated in 24-5%, which is three times ...
gut.bmj4d
P135 Efficacy and safety of 144 weeks of bulevirtide 2 mg or 10 mg monotherapy from the ongoing phase 3 study, MYR301
4 University Hospital of Pisa, Hepatology Unit, Reference Center of the Tuscany Region for Chronic Liver Disease and Cancer, Pisa, Italy 5 Department of Clinical and Experimental Medicine, University ...
gut.bmj4d
The gut-adherent microbiota of PSC–IBD is distinct to that of IBD
1 National Institute for Health Research (NIHR) Birmingham, Liver Biomedical Research Unit, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK Primary sclerosing ...
gut.bmj4d
PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis
Background Mounting epidemiological evidence supports a role for phosphatase and tensin homologue (PTEN)-T cell leukaemia 1 (Tcl1) signalling deregulation in hepatocarcinogenesis. Objective To ...